Robert L. Rosiello
Director/Board Member at The Catholic Charities of the Archdiocese of New York
Net worth: - $ as of 31/12/2023
Network origin in Robert L. Rosiello first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.
171
| Private Company | Investment Managers | 171 |
The Catholic Charities of the Archdiocese of New York
 The Catholic Charities of the Archdiocese of New York Miscellaneous Commercial ServicesCommercial Services The Catholic Charities of the Archdiocese of New York operates as non-profit organization. It protects and nurtures children and youth; feeds the hungry and shelters the homeless; strengthens families and resolving crisis; supports the physically and emotionally challenged; and welcomes and integrates immigrants and refugees. The company was founded in 1917 and is headquartered in New York, NY.
48
| Non-Profit Organization | Miscellaneous Commercial Services | 48 |
| Public Company | Pharmaceuticals: Other | 31 | |
14
| Public Company | Biotechnology | 14 |
| Public Company | Pharmaceuticals: Major | 12 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Robert L. Rosiello via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Massachusetts Institute of Technology | College/University | Director/Board Member Doctorate Degree Doctorate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
| SERES THERAPEUTICS, INC. | Biotechnology | Founder Founder Founder Director of Finance/CFO Chairman Chief Operating Officer | |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Generate Biomedicines, Inc. is a drug generation company that has developed a machine learning-powered multimodality generative biology platform capable of generating new drugs on demand across a wide range of biologic modalities. Generate Biomedicines is based in Somerville, MA. The platform seamlessly integrates computational and wet lab capabilities, improving the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company's platform represents a potentially fundamental shift in what's possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. The company was founded in 2018 by Poorya Hosseini, Molly Gibson, Geoffrey von Maltzahn, Avak Kahvejian, Gevorg Grigoryan. Michael T. Nally has been the CEO of the company since 2018. | Biotechnology | Founder Director/Board Member Founder Director/Board Member Founder Chief Executive Officer | |
| MODERNA, INC. | Biotechnology | Director/Board Member Director/Board Member Founder Chief Executive Officer Director/Board Member | |
Montai Health, Inc.
 Montai Health, Inc. Packaged SoftwareTechnology Services Montai Health, Inc. is a company that is using its pioneering AI-powered Conecta™ platform to develop Anthromolecule™ medicines that will treat and preempt chronic diseases to improve health outcomes for the 2 billion people worldwide living with these diseases. The company is based in Cambridge, MA. Montai Health is unlocking the potential of Anthromolecule™ chemistry with its pioneering AI-powered Conecta™ platform to develop breakthrough small-molecule medicines that will treat and preempt chronic diseases to improve health outcomes for the two billion people worldwide living with these diseases. The company was founded by Hok Hei Tam, Michael Wong, David Kolesky, Mary Margaret Hastings Georgiadis. Mary Margaret Hastings Georgiadis has been the CEO since incorporation. | Packaged Software | Director/Board Member Chairman Founder Chief Operating Officer Founder | |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Founder Chief Executive Officer Director/Board Member | |
Ohana Biosciences, Inc.
 Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| RUBIUS THERAPEUTICS | Biotechnology | Founder Director/Board Member President Director of Finance/CFO | |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Founder Chief Executive Officer Founder Chairman | |
| BG MEDICINE, INC. | Medical Specialties | Chairman Founder Director of Finance/CFO Chairman | |
Indigo Ag, Inc.
 Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Biotechnology | Founder Founder Director/Board Member Founder | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Founder Chief Administrative Officer Founder | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Doctorate Degree | |
Inzen Therapeutics, Inc.
 Inzen Therapeutics, Inc. BiotechnologyHealth Technology Part of Sonata Therapeutics, Inc., Inzen Therapeutics, Inc. is discovering and developing a novel class of medicines based on thanokine biology. The company is based in Cambridge, MA. Thanokine biology offers the potential for unprecedented approaches to prevent and treat cancer, fibrotic disorders, immune-inflammatory disorders, metabolic disorders, and degenerative diseases. Inzen's thanokine product platform applies advances in mass spectrometry and machine learning, novel probes, unique assays, genetic and chemical biological technologies to characterize thanokine biology at scale and create drug candidates. Inzen Therapeutics harnesses signals of the cellular microenvironment to treat serious diseases. The company was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability. | Biotechnology | Director/Board Member Director/Board Member President | |
Cygnal Therapeutics, Inc.
 Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder Director/Board Member | |
| SYNERGETICS USA INC | Medical Specialties | Director/Board Member Chief Executive Officer Director/Board Member | |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member General Counsel President | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| EXACT SCIENCES CORPORATION | Medical Specialties | Director of Finance/CFO Director/Board Member Founder | |
Tessera Therapeutics, Inc.
 Tessera Therapeutics, Inc. BiotechnologyHealth Technology Tessera Therapeutics, Inc. engages in science company. It offers scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder Director/Board Member | |
| OMEGA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Founder Founder | |
Cobalt Biomedicine, Inc.
 Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Cobalt Biomedicine, Inc. engages in the development of therapeutic based drugs. The company was founded in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor Corporate Officer/Principal | |
| University of California San Diego | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree | |
| University of Wisconsin | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
| BAUSCH + LOMB CORPORATION | Medical Specialties | Chief Executive Officer Director/Board Member President | |
| T2 BIOSYSTEMS, INC. | Medical Specialties | Director/Board Member Director/Board Member Founder | |
| REALM THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Blackfynn, Inc.
 Blackfynn, Inc. Internet Software/ServicesTechnology Services Blackfynn, Inc. provides treatments for neurological disease. Its new tools and technologies are generating. The company was founded by Amanda Christini and Joost Wagenaar and is headquartered in Philadelphia, PA. | Internet Software/Services | Chairman Director/Board Member | |
| King's College London | College/University | Doctorate Degree Graduate Degree | |
moksha8 Pharmaceuticals, Inc.
 moksha8 Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Founder President | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Director of Finance/CFO Corporate Officer/Principal | |
| CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
VisEn Medical, Inc.
 VisEn Medical, Inc. Medical/Nursing ServicesHealth Services VisEn's in vivo fluorescence imaging technologies, including its Fluorescence Agent Portfolio and its Fluorescence Molecular Tomographic (FMTTM) Imaging Systems provide robust fluorescence molecular imaging performance in identifying, characterizing and quantifying ranges of disease biomarkers and therapeutic efficacy in vivo. VisEn's FMT systems and agents are used by leading research institutions and pharmaceutical companies in applications including cancer research, inflammation, cardiovascular, skeletal and pulmonary disease. The company also works with large pharmaceutical partners to design ranges of tailored molecular imaging agents and applications that are designed to their specific pre-clinical and clinical research areas. | Medical/Nursing Services | Director/Board Member Chairman |
Statistics
International
| United States | 46 |
| United Kingdom | 4 |
| Canada | 2 |
| France | 2 |
Sectoral
| Health Technology | 32 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Technology Services | 3 |
| Finance | 2 |
Operational
| Director/Board Member | 379 |
| Corporate Officer/Principal | 121 |
| Founder | 87 |
| Undergraduate Degree | 70 |
| Chief Executive Officer | 70 |
Most connected contacts
| Insiders | |
|---|---|
| Noubar Afeyan | 76 |
| Robert Rosewell Chai-Onn | 75 |
| Harry Wilcox | 33 |
| David Berry | 31 |
| Ed Kania | 31 |
| Michael Rosenblatt | 31 |
| Joseph Papa | 28 |
| John Mendlein | 27 |
| Theo Melas-Kyriazi | 26 |
| Stéphane Bancel | 23 |
| Catherine Kinney | 22 |
| Sarah Kavanagh | 19 |
| Lord Darzi | 18 |
| Geoffrey von Maltzahn | 15 |
| Christina Ackermann | 15 |
- Stock Market
- Insiders
- Robert L. Rosiello
- Company connections
